Biotech stocks can be incredibly attractive for risk-taking investors because of their ability to go parabolic in an instant.

Danish biotech Gubra A/S said its experimental obesity drug showed weight loss and mild side effects in a small study, ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

This month IssueVoter and BillTrack50 take a look at the BIOSECURE Act, a significant escalation in efforts to restrict ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these companies: ...

The existing Goodwill building purchased by Washington University in 2019 and a planned expansion, right, are shown in this ...

When City Manager Aaron Busch attended his first Biotech International conference as a member of the city’s staff, he found ...